Radiosensitization by an anti-EGFR single chain antibody in human head and neck cancer cells

被引：0
|
作者：
Bonner, J. [1 ]
Trummell, H. Q. [1 ]
Sanford, L. L. [1 ]
Raisch, K. P. [1 ]
机构：
[1] Univ Alabama, Birmingham, AL USA
来源：
RADIOTHERAPY AND ONCOLOGY | 2007年 / 82卷
关键词：
D O I：
10.1016/S0167-8140(07)80098-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
98
引用
收藏
页码：S32 / S33
页数：2
相关论文
共 50 条
  • [31] Are Fusion Transcripts in Relapsed/Metastatic Head and Neck Cancer Patients Predictive of Response to Anti-EGFR Therapies?
    Bossi, Paolo
    Siano, Marco
    Bergamini, Cristiana
    Rocca, Maria Cossu
    Sponghini, Andrea P.
    Giannoccaro, Marco
    Tonella, Luca
    Paoli, Alessandro
    Marchesi, Edoardo
    Perrone, Federica
    Pilotti, Silvana
    Locati, Laura D.
    Canevari, Silvana
    Licitra, Lisa
    De Cecco, Loris
    DISEASE MARKERS, 2017, 2017
  • [32] Colorectal cancer cells are resistant to anti-EGFR monoclonal antibody through adapted autophagy
    Chen, Zhi
    Gao, Shuohui
    Wang, Dayv
    Song, Defeng
    Feng, Ye
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2016, 8 (02): : 1190 - 1196
  • [33] Cloning and Expression of the Variable Regions of Anti-EGFR Monoclonal Antibody in E-coli for Production of a Single Chain Antibody
    Jalalypour, Farzaneh
    Farajnia, Safar
    Mahmoudi, Fatemeh
    Baradaran, Behzad
    Farajzadeh, Davoud
    Rahbarnia, Leila
    Majidi, Jafar
    IRANIAN JOURNAL OF BIOTECHNOLOGY, 2014, 12 (02)
  • [34] Concurrent chemoradiation (CCRT) or radiotherapy with anti-EGFR directed monoclonal antibody (anti-EGFR) or CCRT plus anti-EGFR in locoregionally advanced head-and-neck squamous cell carcinoma (LA-HNSCC): a comprehensive review of randomized data
    Specenier, P.
    Janssens, K.
    Vermorken, J. B.
    EUROPEAN JOURNAL OF CANCER, 2017, 72 : S105 - S106
  • [35] Efficacy and safety of MCLA-129, an anti-EGFR/c-MET bispecific antibody, in head and neck squamous cell cancer (HNSCC)
    Bossi, P.
    Minuti, G.
    Brana, I.
    Garcia, V. Moreno
    Boni, V.
    Jamme, P.
    Call, J. A.
    Yan, C.
    Barasa, B.
    Doze, P.
    Joe, A. K.
    Laus, G.
    Daste, A.
    ANNALS OF ONCOLOGY, 2023, 34 : S1610 - S1611
  • [36] Use of the humanized anti-EGFR monoclonal antibody h-R3 and radiotherapy in the treatment of advanced head and neck cancer patients.
    Crombet, T
    Osorio, M
    Cruz, T
    Renginfo, E
    Díaz, JR
    Del Castillo, R
    Torres, O
    Pérez, R
    Lage, A
    CLINICAL CANCER RESEARCH, 2000, 6 : 4558S - 4558S
  • [37] Panitumumab.: Oncolytic -: Anti-EGFR human monoclonal antibody.
    McIntyre, JA
    Martín, L
    DRUGS OF THE FUTURE, 2004, 29 (08) : 793 - 797
  • [38] Radiosensitization of head and neck cancer cells by the phytochemical agent sulforaphane
    Kotowski, Ulana
    Heiduschka, Gregor
    Brunner, Markus
    Czembirek, Cornelia
    Eder-Czembirek, Christina
    Schmidt, Rainer
    Fahim, Tammer
    Thurnher, Dietmar
    STRAHLENTHERAPIE UND ONKOLOGIE, 2011, 187 (09) : 575 - 580
  • [39] h-R3. Treatment of head and neck cancer - Treatment of epithelial tumors anti-EGFR MAb
    Ramos, TC
    Parada, AC
    Escobar, NI
    DRUGS OF THE FUTURE, 2003, 28 (09) : 847 - 853
  • [40] RON receptor tyrosine kinase in head and neck cancer: a potential target for overcoming resistance to anti-EGFR therapy
    Lu, Zhixin
    Takiar, Vinita
    Waltz, Susan E.
    CANCER RESEARCH, 2023, 83 (07)
12345